The Effect of Continuous Monitoring Versus Routine Spot-checks on Altered Vital Signs in Patients Recovering From Non-cardiac Surgery on Normal Wards the COME ON, NOW Trial

What this Trial Is About

Researchers are investigating whether continuous vital sign monitoring after non-cardiac surgery can reduce the time patients spend with abnormal vital signs compared to routine spot-checks by nurses. This randomized, single-center trial focuses on adults recovering on normal hospital wards, as most serious complications and deaths occur during the early postoperative period when vital sign changes may be missed due to infrequent checks. Participants will be assigned to one of two groups one with continuous vital sign monitoring using a wearable, wireless sensor where data are recorded but not shared with clinicians, and another group where the same monitoring is unblinded, allowing clinicians to receive real-time alerts for abnormal oxygen levels, heart rate, blood pressure, and respiratory rate. These alerts may prompt timely clinical interventions. The primary evaluation will measure the total duration of abnormal vital signs during the first 48 hours after admission to the normal ward. During the study, patients will have their vital signs monitored continuously with the wearable sensor for 48 hours on the ward. Researchers will analyze clinical interventions triggered by vital sign abnormalities and assess serious in-hospital complications. The study aims to improve early detection of patient deterioration after surgery to reduce complications and improve outcomes. Participation includes monitoring and data collection during the first two days after surgery in the normal ward setting.

Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery